Skip to main content
. Author manuscript; available in PMC: 2014 Oct 15.
Published in final edited form as: Fam Cancer. 2010 Jun;9(2):173–179. doi: 10.1007/s10689-009-9307-z

Figure 2.

Figure 2

A) ELISA ODs for the single FSPs in MSI-H CRC patients in relation to time after tumor resection. B) OD of the highest reactive FSP for each serum in MSI-H CRC patients in relation to time after tumor resection.